Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2026-01-13 00:00:00 ET · period of report 2026-01-10 · accession 0001193125-26-012080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-13 | 2026-01-10 | TMCI | Treace John T. | CEO, Dir, 10% | F - Tax | $0.00 | -13.2K | 6.78M | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-10 | F | D | 13,219 | $0.00 | 6,775,887 | D | — | — | (F1) Includes 363,867 restricted stock units. |